Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160035/S058

EXCOR Pediatric Ventricular Assist Device

Berlin Heart, Inc. · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONP160035/S058

What did the FDA approve?

The FDA's decision record for P160035/S058, dated 2026-09-01, lists a normal 180-day track supplement for the EXCOR Pediatric Ventricular Assist Device (product code DSQ, ventricular assist bypass, applicant Berlin Heart, Inc.). The stated purpose is approval of a shortened trocar in the de-airing set, filed under change design/components/specifications/material. That describes a component modification within an existing device rather than a new system approval.

The supplement number indicates this action belongs to the original PMA P160035, and the filing concerns a specification or material change to one part. The record does not state trocar dimensions, material, de-airing procedure details, testing performed or review basis, so the rationale for the modification cannot be described from the supplied fields. The listed approval purpose is the agency's stated action and is not independent evidence of safety or clinical effectiveness for the changed component or the system.

FDA approval order statement

Approval for a shortened trocar in the de-airing set
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Sep 1, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160035/S058
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
APPR
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160035 · Original PMA

    EXCOR Pediatric Ventricular Assist Device

  2. P160035/S058 received

    Application receipt date recorded by FDA.

  3. P160035/S058 · FDA decision

    Normal 180 Day Track

  4. P160035/S057 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  5. P160035/S060 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  6. P160035/S054 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

Timeline entries are records held by MedtechLedger for P160035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160035

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA approvalJun 6, 2017FDA
Berlin Heart, Inc.PMA supplementOct 1, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
HeartMate II LVASP060040/S128
ABBOTT MEDICALPMA supplementOct 1, 2026FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Berlin Heart, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9391 Grogan'S Mill Rd., Suite A-6, The Woodlands, TX, 77380

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records